1. Home
  2. VSTM vs EOLS Comparison

VSTM vs EOLS Comparison

Compare VSTM & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verastem Inc.

VSTM

Verastem Inc.

HOLD

Current Price

$6.95

Market Cap

395.4M

Sector

Health Care

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$8.12

Market Cap

384.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSTM
EOLS
Founded
2010
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
395.4M
384.6M
IPO Year
2011
2018

Fundamental Metrics

Financial Performance
Metric
VSTM
EOLS
Price
$6.95
$8.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
5
Target Price
$16.50
$15.50
AVG Volume (30 Days)
2.2M
932.4K
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
17.49
1.23
EPS
N/A
N/A
Revenue
$30,914,000.00
$297,176,000.00
Revenue This Year
$282.64
$13.27
Revenue Next Year
$72.25
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
209.14
11.61
52 Week Low
$3.43
$3.86
52 Week High
$11.25
$8.43

Technical Indicators

Market Signals
Indicator
VSTM
EOLS
Relative Strength Index (RSI) 71.43 74.39
Support Level $6.68 $5.84
Resistance Level $7.05 N/A
Average True Range (ATR) 0.42 0.39
MACD 0.06 0.27
Stochastic Oscillator 86.94 90.22

Price Performance

Historical Comparison
VSTM
EOLS

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: